跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
STRENSIQ - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
STRENSIQ
Authorized
STANDARD
STRENSIQ
Alexion Pharma GmbH
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3fec162d5f8ccbe2
Company
Alexion Pharma GmbH
Type
Standard
Approval Details
Approval Id
3fec162d5f8ccbe2
Drug Approval Canada Name
STRENSIQ
Product Name
STRENSIQ
Status
Marketed
Status Date
2016-06-01
Original Market Date
2016-06-01
Din
02444631
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
Prescription , Schedule D
Ahfs
44:00.00
Atc Original
A16AB13 ASFOTASE ALFA
Atc Name
a 16 ab 13
Aig Number
0157271001
Company Name
Alexion Pharma GmbH
Company Address
Neuhofstrasse 34, Baar, --, Switzerland, 6340
Company Detail Path
/organization/alexion-pharma-gmbh
Company Information
Pharmaceutical Company Name
Alexion Pharma GmbH
Country Name
Switzerland
Province Name
Zug
City Name
baar,zug,country_ch
Address
Neuhofstrasse 34
Active Ingredients
ASFOTASE ALFA
40 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3fec162d5f8ccbe2
Type
Standard
Back to Health Canada Approvals